Subscribe to Newsletter

Content by Maryam Mahdi:

Business & Regulation Business Practice

A History of Missed Opportunity

| Maryam Mahdi | 13 min read

What role must pharma play to help improve outcomes for women?

Business & Regulation Business Practice

Staying Engaged

| Maryam Mahdi | 3 min read

Ashfield Engage’s Ian Riches explains how companies can make patient engagement a priority.

Manufacture Facilities

The Grand Challenge: Oligonucleotides Under the Microscope

| Maryam Mahdi | 5 min read

How can pharma companies ensure the future success of the oligonucleotide therapeutic market?

Business & Regulation Digital Technologies

On Cloud Nine?

| Maryam Mahdi | 3 min read

What difference can cloud-based systems make to data management?

Business & Regulation Digital Technologies

Three Questions on Data Management in Pharma

| Maryam Mahdi | 4 min read

Data management can be difficult but the right systems can help pharma manage the vast volumes of data it amasses.

Business & Regulation Digital Technologies

Digital Transformation: Veeva la Revolution!

| Maryam Mahdi | 4 min read

What difference will decentralized trials make to the future of clinical trials?

Business & Regulation Business Practice

Roe v. Wade and the Future of Medical Abortions in the US

| Maryam Mahdi | 2 min read

How will pharma companies navigate America’s new abortion laws?

Business & Regulation Profession

Demystifying Cancer R&D

| Maryam Mahdi | 5 min read

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

Discovery & Development Clinical Trials

Video: How Can Pharma Improve Clinical Trials?

| Maryam Mahdi

How pharma is working to develop efficient and patient-centric trials.

Business & Regulation Digital Technologies

Collaborating for a Cause

| Maryam Mahdi | 6 min read

Can AI help us better understand and define chronic pain?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register